Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Czech is available via eTranslation, the European Commission's machine translation service.

Translate to Czech | Important information about machine translation

Date

Pondělí, 5 Únor 2024, All day
Čtvrtek, 8 Únor 2024, All day

Místo konání

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Poprvé zveřejněno: Poslední aktualizace:
Zobrazit

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Poprvé zveřejněno:
Zobrazit

Share this page